Vets Can Finally Talk CBD With Pet Owners — 2026 Law Changes Explained

The Conversation Your Vet Has Been Afraid to Have

For years, a bizarre and deeply frustrating dynamic has played out in veterinary clinics across the country. Pet owners, increasingly aware that cannabidiol (CBD) and other hemp-derived compounds might help their arthritic golden retriever or anxious rescue cat, walk into their vet's office looking for guidance. And the vet — trained, licensed, and genuinely wanting to help — responds with a vague non-answer, a change of subject, or an uncomfortable silence.

It wasn't that veterinarians didn't know about CBD. Many had been closely following the growing body of research on cannabinoid-based treatments for animals. The problem was legal: in most states, recommending or even discussing cannabis products for animals could jeopardize a veterinarian's license. State veterinary boards, following federal guidelines that classified all cannabis-derived products as controlled substances, treated any professional engagement with these products as a potential disciplinary matter.

In 2026, that is finally changing. A growing wave of state legislation is explicitly protecting veterinarians who discuss hemp-derived CBD and cannabis treatment options with their clients, removing the professional risk that has kept these conversations in the shadows.

Maryland Leads the Latest Wave

The most recent breakthrough came in March 2026, when Maryland delegates unanimously passed a bill protecting veterinarians from licensing board discipline when they discuss cannabis treatment options for pets. The unanimous vote — in a legislature that can be contentious on cannabis issues — signaled a broad consensus that the veterinary profession should not be penalized for engaging with a rapidly evolving area of animal health.

Maryland's bill does not allow veterinarians to prescribe or dispense cannabis products. Instead, it creates a legal safe harbor for professional discussion. Veterinarians can now explain the potential benefits and risks of CBD products, recommend dosing ranges based on available research, discuss product quality considerations like third-party testing and COA (Certificate of Analysis) verification, and help pet owners make informed decisions about incorporating CBD into their animal's care plan.

This distinction between discussion and prescription is critical. Under federal law, cannabis remains a controlled substance, and veterinarians — like human physicians — cannot technically "prescribe" it. But the Maryland law ensures that having a conversation about it won't trigger an investigation or a license review.

The States That Paved the Way

Maryland joins a growing list of states that have enacted similar protections. California was among the first, passing AB 2215 in 2018, which explicitly allowed veterinarians to discuss cannabis as a treatment option. Colorado followed with its own protections, and Oregon expanded its veterinary practice laws to include cannabis discussions.

Nevada passed legislation in 2023 that went further than most states, allowing veterinarians to recommend CBD products and even requiring them to complete continuing education on cannabinoid therapy for animals. This makes Nevada one of the most progressive states for veterinary cannabis access.

The common thread across all these laws is protection without authorization. States are not creating new drug categories or approving specific products for veterinary use. They are simply removing the professional jeopardy that made veterinarians reluctant to share their knowledge with the pet owners who need it.

Why CBD for Pets Isn't Fringe Science

The scientific basis for cannabinoid therapy in animals has strengthened considerably in recent years. Dogs and cats, like all mammals, possess an endocannabinoid system (ECS) — a network of receptors and signaling molecules that plays a role in pain modulation, immune function, mood regulation, and gastrointestinal health.

Research from Cornell University's College of Veterinary Medicine has been particularly influential. A landmark 2018 study found that CBD oil significantly reduced pain and increased activity in dogs with osteoarthritis, with minimal side effects. Subsequent studies have explored CBD's potential for managing epilepsy, anxiety, and inflammatory conditions in dogs and cats.

The safety profile of CBD in animals is generally favorable. Research indicates that CBD administration to dogs is well-tolerated for short-term use, with adverse effects such as loose stools and vomiting documented in only 0.45 to 3.3 percent of dogs receiving CBD. More and more veterinarians are using CBD-containing products to reduce pain, anxiety, gastrointestinal issues, and seizures in companion animals.

A 2025 systematic review published in the Journal of the American Veterinary Medical Association examined 34 clinical studies on CBD use in dogs and cats. The review found consistent evidence of analgesic effects, with moderate evidence supporting anxiolytic and anticonvulsant properties. The authors noted that while the research base is still developing, the existing evidence is stronger than for many nutraceutical supplements routinely discussed in veterinary practice.

The $600 Million Market Growing in the Shadows

Even without widespread veterinary endorsement, the CBD pet products market has exploded. Industry analysts estimate the market at approximately $600 million in 2026, with a compound annual growth rate of 33 percent projected through the next decade.

This growth has occurred largely through direct-to-consumer channels. Pet owners have been purchasing CBD oils, treats, and topical products from online retailers, pet specialty stores, and cannabis dispensaries — often without any professional guidance on dosing, product quality, or potential drug interactions.

The disconnect between market growth and veterinary involvement has created genuine safety concerns. Without professional guidance, pet owners may select products with inaccurate labeling, inconsistent CBD concentrations, or potentially harmful contaminants. A 2024 analysis of commercially available pet CBD products found that nearly 40 percent contained significantly more or less CBD than advertised, and several tested positive for heavy metals or pesticide residues.

This is precisely why veterinary involvement matters. When veterinarians can openly discuss CBD, they can help pet owners navigate product quality, identify reliable brands that provide third-party testing, establish appropriate dosing protocols based on the animal's weight, condition, and other medications, and monitor for adverse effects or drug interactions.

The FDA's Evolving Position

The federal regulatory landscape for pet CBD products remains complex. As of early 2026, no cannabis-derived animal products are federally approved by the FDA. However, the agency has shown increasing engagement with the issue.

In January 2025, the FDA published a Request for Information in the Federal Register, inviting public and industry stakeholders to comment on cannabis-derived products in veterinary use. The comment period closed in spring 2025, and based on the momentum from this veterinary cannabis docket, new federal guidelines or enforcement clarifications are expected by mid-2026.

The FDA's increasing engagement signals a recognition that the market for pet CBD products already exists at scale, and that regulation — rather than prohibition — is the more practical approach. Industry watchers expect the FDA to establish quality standards for pet CBD products, including requirements for accurate labeling, contaminant testing, and Good Manufacturing Practices (GMP) compliance.

What Pet Owners Should Know Right Now

If you're considering CBD for your pet, the changing legal landscape means you may be able to have a more productive conversation with your veterinarian than was possible even a year ago. Here are the key considerations.

Start with your vet. Even if your state hasn't passed explicit protection legislation, many veterinarians are becoming more comfortable discussing CBD. Ask directly, and be prepared for a candid conversation about the evidence base, which is promising but still evolving.

Prioritize product quality. Look for products that provide a Certificate of Analysis from an independent third-party laboratory. This document should confirm the CBD concentration, verify that THC levels are below 0.3 percent, and test for contaminants including heavy metals, pesticides, and residual solvents.

Understand dosing. Research suggests that effective CBD doses for dogs typically range from 2 to 8 milligrams per kilogram of body weight, depending on the condition being treated. Start at the low end and increase gradually, monitoring your pet's response.

Watch for interactions. CBD can affect how the liver metabolizes certain medications. If your pet is on other drugs — particularly anti-seizure medications, NSAIDs, or blood thinners — discuss potential interactions with your vet before starting CBD.

Be patient. Unlike many pharmaceutical interventions, CBD's effects may take days or weeks to become apparent, particularly for chronic conditions like arthritis or anxiety. Consistent dosing over time typically produces better results than sporadic use.

Looking Ahead: The Path to Full Integration

The trend toward protecting veterinary cannabis discussions is accelerating, and it seems likely that most states with legal cannabis programs will adopt similar protections within the next few years. The unanimity of Maryland's vote suggests that this is becoming a bipartisan issue — protecting professional communication about a product that millions of pet owners are already using.

The longer-term trajectory points toward even deeper integration of cannabinoid therapy into veterinary practice. As the research base expands, the FDA formalizes quality standards, and veterinary schools incorporate cannabinoid education into their curricula, the awkward silence that has characterized vet-client cannabis conversations will become a relic of a transitional era.

For the 67 percent of American households that include a pet, the ability to have an honest, evidence-based conversation with their veterinarian about CBD is not a luxury — it's a fundamental component of responsible pet care. The laws catching up to this reality in 2026 represent a meaningful step forward for animal health, veterinary practice, and the millions of pet owners who have been navigating this space alone.